New strategies to target Bcr-Abl with ATP-competitive and allosteric inhibitors

被引：0
|
作者：
Hantschel, O. [1 ]
机构：
[1] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：199 / 199
页数：1
相关论文
共 50 条
  • [1] The Growing Arsenal of ATP-Competitive and Allosteric Inhibitors of BCR-ABL
    Hantschel, Oliver
    Grebien, Florian
    Superti-Furga, Giulio
    CANCER RESEARCH, 2012, 72 (19) : 4890 - 4895
  • [2] Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors
    Zhang, Jianming
    Adrian, Francisco J.
    Jahnke, Wolfgang
    Cowan-Jacob, Sandra W.
    Li, Allen G.
    Iacob, Roxana E.
    Sim, Taebo
    Powers, John
    Dierks, Christine
    Sun, Fangxian
    Guo, Gui-Rong
    Ding, Qiang
    Okram, Barun
    Choi, Yongmun
    Wojciechowski, Amy
    Deng, Xianming
    Liu, Guoxun
    Fendrich, Gabriele
    Strauss, Andre
    Vajpai, Navratna
    Grzesiek, Stephan
    Tuntland, Tove
    Liu, Yi
    Bursulaya, Badry
    Azam, Mohammad
    Manley, Paul W.
    Engen, John R.
    Daley, George Q.
    Warmuth, Markus
    Gray, Nathanael S.
    NATURE, 2010, 463 (7280) : 501 - U116
  • [3] Inhibitors in AKTion: ATP-competitive vs allosteric
    Lazaro, Glorianne
    Kostaras, Eleftherios
    Vivanco, Igor
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2020, 48 (03) : 933 - 943
  • [4] Allosteric inhibitors of Bcr-abl–dependent cell proliferation
    Francisco J Adrián
    Qiang Ding
    Taebo Sim
    Anastasia Velentza
    Christine Sloan
    Yi Liu
    Guobao Zhang
    Wooyoung Hur
    Sheng Ding
    Paul Manley
    Jürgen Mestan
    Doriano Fabbro
    Nathanael S Gray
    Nature Chemical Biology, 2006, 2 : 95 - 102
  • [5] Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
    Afsar Ali Mian
    Anna Metodieva
    Susanne Badura
    Mamduh Khateb
    Nili Ruimi
    Yousef Najajreh
    Oliver Gerhard Ottmann
    Jamal Mahajna
    Martin Ruthardt
    BMC Cancer, 12
  • [6] Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
    Mian, Afsar Ali
    Metodieva, Anna
    Badura, Susanne
    Khateb, Mamduh
    Ruimi, Nili
    Najajreh, Yousef
    Ottmann, Oliver Gerhard
    Mahajna, Jamal
    Ruthardt, Martin
    BMC CANCER, 2012, 12
  • [7] Allosteric inhibition of BCR-ABL
    Hassan, A. Quamrul
    Sharma, Sreenath V.
    Warmuth, Markus
    CELL CYCLE, 2010, 9 (18) : 3710 - 3714
  • [8] Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment
    Garcia-Echeverria, Carlos
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (15) : 4308 - 4312
  • [9] Targeted inhibition of Gatekeeper variant "T315I" of BCR-ABL by a purine based ATP-competitive inhibitor
    Azam, Mohammad
    Shakespeare, William C.
    Sawyer, Tomi K.
    Daley, George Q.
    CANCER RESEARCH, 2006, 66 (08)
  • [10] Latent allosteric control of protein interactions by ATP-competitive kinase inhibitors
    Vaisar, David
    Ahn, Natalie G.
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2024, 89
12345